Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ABL1 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

ABL1 exon 4 deletion + ABL1 T315I (2)

BCR-ABL1 F317I + ABL1 F317C (1)

BCR-ABL1 F317I + ABL1 F317C + ABL1 F1317L (1)

BCR-ABL1 T315I + ABL1 E255K (1)

BCR-ABL1 T315I + ABL1 E255V (1)

BCR-ABL1 fusion + SET underexpression (1)

NUP214-ABL1 rearrangement (1)

RANBP2-ABL1 T315I + ABL1 L302H (0)

ABL1 exon 4 deletion + ABL1 T315I (2)

BCR-ABL1 F317I + ABL1 F317C (1)

BCR-ABL1 F317I + ABL1 F317C + ABL1 F1317L (1)

BCR-ABL1 T315I + ABL1 E255K (1)

BCR-ABL1 T315I + ABL1 E255V (1)

BCR-ABL1 fusion + SET underexpression (1)

NUP214-ABL1 rearrangement (1)

RANBP2-ABL1 T315I + ABL1 L302H (0)

›

ABL1 expression

Acute Myelogenous Leukemia

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials